Focus on Alternative and Complementary Therapies
© 2014 Royal Pharmaceutical Society
Edited By: Edzard Ernst, Peninsula Medical School, UK
Online ISSN: 2042-7166
Focus on Alternative and Complementary Therapies (FACT) publishes commentaries on current literature in complementary and alternative medicine (CAM). In addition, FACT is soliciting original articles. Manuscripts should be submitted online via ScholarOne Manuscripts. Full instructions and support are available on the site and a user ID and password can be obtained on the first visit. For technical support please dial +1 434 817 2040 ext. 167, or via the 'Get Help Now' link in the top right-hand corner of the login screen. If you cannot submit online, please contact the Editorial Office.
Manuscript Types Accepted:
Original or Review articles should not normally exceed 3000 words. They should contain a structured abstract (not exceeding 250 words, and using the following headings: Background; Objectives; Methods; Results; Conclusions), 5 keywords, a maximum of 5 tables and/or figures and up to 100 references. Authors are encouraged to structure their article with appropriate subheadings. Manuscripts that do not meet these criteria will be returned to the authors for revision prior to formal consideration.
Perspective articles should not normally exceed 3000 words. They need no abstract, will not normally have tables or figures and should have no more that 20 references. Authors are requested to supply five keywords. Authors are encouraged to structure their article with appropriate subheadings. Manuscripts that do not meet these criteria will be returned to the authors for revision prior to formal consideration.
Debate articles present different or even opposing views in controversial areas. If you are interested in taking part in a debate article please contact the Editor-in-Chief.
Summaries and commentaries are solicited from editorial board members (unsolicited submissions will not be accepted for publication). The authors of the original article are offered right of reply.
Letters should not exceed 500 words and minimal references. An abstract is not required for letters. Editorials are solicited (unsolicited submissions will not be accepted for publication).
- Authors should supply a conflict of interest statement with their submitted manuscript, detailing any financial or personal relationships that may bias their work, or a declaration that they have no conflicts of interest to disclose.
- Original research studies involving animals or human volunteers must include details of ethical approval. Papers that do not comply with internationally accepted ethical criteria will not be accepted for publication.
- Identifying details of patients and study participants should be omitted. If identifying information is essential for scientific purposes, or if there is any doubt about the adequacy of the anonymity protection used, the patient (or parent/guardian) must give written informed consent for publication. Authors should provide this statement of informed consent upon submission of the manuscript.
- Manuscripts reporting randomised controlled trials should include a checklist and flowchart in accordance with the CONSORT Statement guidelines. The checklist should be submitted as a supplementary file, and the flowchart as a figure.
- Systematic reviews must be submitted together with a checklist and flowchart in accordance with the PRISMA guidelines. The checklist should be submitted as a supplementary file, and the flowchart as a figure.
Manuscript Style and Format:
Title. Concise and informative title.
Authors. Names department(s) and institution(s) of all authors.
Corresponding author. Name, address, email address, telephone and fax numbers. (Corresponding author should take responsibility for communicating with all other authors and getting their approval for the final version to be published. During online submission corresponding authors can nominate an individual, who may or may not be an author, to assist them with administration of the publication process.)
Funding. Any financial support for the study or the manuscript must be disclosed, regardless of its source, including a short description of involvement of the funder in study design, data collection, data analysis, manuscript preparation and/or publication decisions. If none, state "none".
Acknowledgements. Nonfinancial support (e.g. donations of drugs or devices) and individuals who contributed to the study or the manuscript but do not quality as authors must be acknowledged. If none, state "none".
Disclosures. Each author must disclose all financial relationships for the previous 12 months, whether or not they are related to the subject of the paper. This should include equity ownership, profit-sharing agreements, royalties, patents, and grants. Income from pharmaceutical companies should be specified by type, e.g. speaker's honoraria, expenses, grants, etc. Authors do not need to report the sums concerned. If none, state "none".
Prior Publication. You will be asked during online submission to confirm that the submitted work is not published, in press or currently being considered for publication elsewhere.
Tables. All tables should be mentioned in the text and individually numbered. Tables should be presented together and separated from the main text. They should be numbered in the order in which they are mentioned in the text, and each should have a short explanatory caption. Each table column should have a short heading. Any tables previously published should be submitted with the written consent of the copyright holder, an acknowledgement should be included in the caption, and the full reference included in the reference list.
Figures. For detailed information about preparing and submitting digital images, please register at the Wiley-Blackwell Author Services website and refer to the 'Author Resources' pages.
Figures will only be accepted if provided electronically (TIFF preferred; JPEG, GIF, EPS, PNG Microsoft PowerPoint, Microsoft Excel also acceptable); they should be professionally drawn, labeled and photographed; freehand lettering is not acceptable. Staining techniques and the magnification of micrographs should be stated, and arrows/abbreviations explained in the captions. If the subjects of photographs are identifiable, either their eyes should be masked or their written permission to use the photograph be submitted with the manuscript. Any information (including personal data) that could enable a patient to be identified should be removed.
All illustrations and figures should be mentioned in the text and individually numbered. Only those essential to the paper should be included. Illustrations and figures should be presented together and separated from the main text. They should be numbered in the order in which they are mentioned in the text, and each should have a short explanatory caption. Any illustrations and figures previously published should be submitted with the written consent of the copyright holder, an acknowledgement should be included in the caption, and the full reference included in the list. Illustrations may be reproduced in colour if essential to the article. A charge will be made for colour reproduction. If colour is required, a Colour Work Agreement Form must be completed and returned to the Editorial Office. Any article received with colour work will not be published until this form has been returned.
Measurements, abbreviations, drug names. Measurements should be given in the units in which they were made, but non-metric units must be accompanied by metric (SI) equivalents (exceptions: blood pressure in mmHg; haemoglobin in g/dl). Generic drug names should be used (drug brand names must not be used). If an acronym is used, the term for which it stands should be given in full at its first mention in the text, for example, anti-diuretic hormone (ADH).
References. Original textual matter quoted from other authors must have formal citation and be appropriately attributed and referenced. Authors should verify references against the original documents. The Vancouver style is used. References should be identified in the text using superscript numbers, and numbered and listed consecutively at the end of the paper in the order in which they are first cited in the text.
Journals. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-333.
Books. Czarnetzki BM. Urticaria. Berlin: Springer, 1986.
Chapter in book. Clissold SP. Rhinitis. In: Barnes PJ, Mygind N, editors. Budesonide: clinical experience in asthma and rhinitis. Manchester: ADIS Press, 1988;51-64.Supporting Information (online only)
Additional material such as video clips, lengthy Appendices (e.g. extensive reference lists or mathematical formulae/calculations), etc, that are relevant to a particular article but not suitable or essential for the print edition of the Journal, may also be considered for publication. Please refer to all supporting information in the manuscript using Table S1, Figure S1, etc, and supply such information as separate files (i.e. not embedded within the main manuscript). Further information on suitable file formats etc may be found here.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper. The corresponding author MUST submit the CTA as it is a requirement for publication.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below: CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp.
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
Additionally. authors are themselves responsible for obtaining permission to reproduce copyright material from other sources.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley InterScience, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://olabout.wiley.com/WileyCDA/Section/id-406241.html.
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://authorservices.wiley.com/bauthor/onlineopen_order.asp. Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Author Article Self-Promotion
Authors are encouraged to follow these 10 easy ways to ensure maximum promotion of their article following publication.
Early View - FACT is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. They have been fully reviewed, revised and edited for publication, and the authors' final corrections incorporated. Authors cannot make changes to their articles after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows each article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the articles.
Proofs. Proofs must be returned within 3 days of receipt; late return may cause a delay in publication. Please check text, tables, legends, and references very carefully. Page proofs will be sent to authors, and it may be necessary to charge for alterations other than correction of printer's errors. Return proofs by fax (+44 131 226 3803) or return the pdf file with notes attached by e-mail (firstname.lastname@example.org).
Offprints. Upon online publication, many journals give free access to the PDF file of the final, published article. In order to get access, you must register at our Wiley-Blackwell Author Services website. NOTE: Free access to the final PDF offprint or your article will be available via Author Services only. Please therefore sign up for author services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers.